Data Provided by Refinitiv. Minimum 15 minutes delayed.
Developing novel therapeutics for the treatment of rare diseases.
Soleno Therapeutics Announces Updated Top-line Results from Phase III Trial of DCCR for Treatment of Prader-Willi Syndrome
Soleno Therapeutics to Participate in Fireside Chat at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit